AI-generated analysis. Always verify with the original filing.
AVITA Medical, Inc. reported Q4 2025 total revenue of $17.6 million and full-year 2025 revenue of $71.6 million, with net loss of $11.6 million and $48.6 million respectively. The company announced a new $60 million credit facility with Perceptive Advisors LLC and issued 2026 revenue guidance of $80-85 million.
Event Type
Disclosure
Mandatory
Variant
8-K
, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or inc
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press release, dated February 12, 2026, issued by AVITA Medical, Inc. 10
| Metric | Value | Basis |
|---|---|---|
| Revenue | $17.60 | |
| Gross Profit Margin | 81.2% | |
| Operating Expenses | $24.70 | |
| Net Loss | $11.60 | |
| — | ||
| — | ||
| — | ||
| — | ||
| — | ||
| — | ||
| — | ||
| — | ||
| — | ||
| — | ||
| — |